Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Leader

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Pharmacokinetics|April 1, 1995
Pharmacokinetic optimisation of vancomycin therapyW G Leader, M H Chandler, M Castiglia
American Journal of Hospital Pharmacy|September 1, 1994
Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patientsW G Leader, T Tsubaki, M H Chandler
Clinical Pharmacokinetics|September 1, 1996
Integrating pharmacokinetics into point-of-care information systemsW G Leader, S L Pestotnik, M H Chandler
Pharmacotherapy|March 1, 1994
Symptomatology, pulmonary function and response, and T lymphocyte beta 2-receptors during smoking cessation in patients with chronic obstructive pulmonary diseaseW G Leader, K M Wolf, T M Cooper, et al.
Therapeutic Drug Monitoring|October 1, 1993
Influence of serum separator tubes on total and free phenytoin concentrations and dosagesW M Cai, W G Leader, W H Porter, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|April 1, 1995
Pharmacokinetic optimisation of vancomycin therapyW G Leader, M H Chandler, M Castiglia
American Journal of Hospital Pharmacy|September 1, 1994
Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patientsW G Leader, T Tsubaki, M H Chandler
Clinical Pharmacokinetics|September 1, 1996
Integrating pharmacokinetics into point-of-care information systemsW G Leader, S L Pestotnik, M H Chandler
Pharmacotherapy|March 1, 1994
Symptomatology, pulmonary function and response, and T lymphocyte beta 2-receptors during smoking cessation in patients with chronic obstructive pulmonary diseaseW G Leader, K M Wolf, T M Cooper, et al.
Therapeutic Drug Monitoring|October 1, 1993
Influence of serum separator tubes on total and free phenytoin concentrations and dosagesW M Cai, W G Leader, W H Porter, et al.
Pageof 1